0001842455-21-000004.txt : 20211008 0001842455-21-000004.hdr.sgml : 20211008 20211008152033 ACCESSION NUMBER: 0001842455-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211008 DATE AS OF CHANGE: 20211008 EFFECTIVENESS DATE: 20211008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nerio Therapeutics, Inc. CENTRAL INDEX KEY: 0001817835 IRS NUMBER: 842075367 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-416368 FILM NUMBER: 211315176 BUSINESS ADDRESS: STREET 1: 11099 TORREY PINES PARK ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-750-4700 MAIL ADDRESS: STREET 1: 11099 TORREY PINES PARK ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001817835 Nerio Therapeutics, Inc. 11099 N. TORREY PINES ROAD, STE. 290 LA JOLLA CA CALIFORNIA 92037 858-750-4700 DELAWARE None None Corporation true 2019 Sanford J. Madigan, Ph.D. 11099 N. Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Jay Lichter, Ph.D. 11099 N. Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Tighe Reardon 11099 N. Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Stefan Heller 11099 N. Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Biotechnology Decline to Disclose 06b false 2021-08-21 false true false 0 10000005 3500003 6500002 false 5 0 0 0 false Nerio Therapeutics, Inc. /s/ Sanford J. Madigan Sanford J. Madigan Chief Executive Officer 2021-10-07